510 related articles for article (PubMed ID: 22329304)
1. [Heroin addiction].
Hosztafi S
Acta Pharm Hung; 2011; 81(4):173-83. PubMed ID: 22329304
[TBL] [Abstract][Full Text] [Related]
2. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
Stimmel B; Kreek MJ
Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
[TBL] [Abstract][Full Text] [Related]
3. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.
Smolka M; Schmidt LG
Addiction; 1999 Aug; 94(8):1191-8. PubMed ID: 10615734
[TBL] [Abstract][Full Text] [Related]
4. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
Shi J; Zhao LY; Epstein DH; Zhang XL; Lu L
Pharmacol Biochem Behav; 2007 May; 87(1):141-5. PubMed ID: 17532034
[TBL] [Abstract][Full Text] [Related]
5. Ascorbic acid (vitamin C) effects on withdrawal syndrome of heroin abusers.
Evangelou A; Kalfakakou V; Georgakas P; Koutras V; Vezyraki P; Iliopoulou L; Vadalouka A
In Vivo; 2000; 14(2):363-6. PubMed ID: 10836211
[TBL] [Abstract][Full Text] [Related]
6. Craving and illicit heroin use among patients in heroin-assisted treatment.
Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
[TBL] [Abstract][Full Text] [Related]
8. EEG spectral power and mean frequencies in early heroin abstinence.
Polunina AG; Davydov DM
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):73-82. PubMed ID: 14687860
[TBL] [Abstract][Full Text] [Related]
9. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT
Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171
[TBL] [Abstract][Full Text] [Related]
10. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
11. Pleasure into pain: the consequences of long-term opioid use.
White JM
Addict Behav; 2004 Sep; 29(7):1311-24. PubMed ID: 15345267
[TBL] [Abstract][Full Text] [Related]
12. Long-term abstinence syndrome in heroin addicts: indices of P300 alterations associated with a short memory task.
Papageorgiou CC; Liappas IA; Ventouras EM; Nikolaou CC; Kitsonas EN; Uzunoglu NK; Rabavilas AD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1109-15. PubMed ID: 15610923
[TBL] [Abstract][Full Text] [Related]
13. Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?
Gerra G; Maremmani I; Capovani B; Somaini L; Berterame S; Tomas-Rossello J; Saenz E; Busse A; Kleber H
Subst Use Misuse; 2009; 44(5):663-71. PubMed ID: 19360539
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.
de Guglielmo G; Kallupi M; Scuppa G; Demopulos G; Gaitanaris G; Ciccocioppo R
Psychopharmacology (Berl); 2017 Jan; 234(2):223-234. PubMed ID: 27714428
[TBL] [Abstract][Full Text] [Related]
15. Rationale for maintenance pharmacotherapy of opiate dependence.
Kreek MJ
Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
[TBL] [Abstract][Full Text] [Related]
16. [Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients].
Sós I; Kiss N; Csorba J; Gerevich J
Orv Hetil; 2000 Apr; 141(15):783-6. PubMed ID: 10808729
[TBL] [Abstract][Full Text] [Related]
17. The opioids: abuse liability and treatments for dependence.
Ternes JW; O'Brien CP
Adv Alcohol Subst Abuse; 1990; 9(1-2):27-45. PubMed ID: 2198785
[TBL] [Abstract][Full Text] [Related]
18. Association between cholesterol plasma levels and craving among heroin users.
Lin SH; Yang YK; Lee SY; Hsieh PC; Chen PS; Lu RB; Chen KC
J Addict Med; 2012 Dec; 6(4):287-91. PubMed ID: 22895461
[TBL] [Abstract][Full Text] [Related]
19. Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users.
Preller KH; Wagner M; Sulzbach C; Hoenig K; Neubauer J; Franke PE; Petrovsky N; Frommann I; Rehme AK; Quednow BB
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1270-9. PubMed ID: 23219936
[TBL] [Abstract][Full Text] [Related]
20. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Negus SS
J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
